These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11170949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
    Chakrabarti S, Collingham KE, Holder K, Oyaide S, Pillay D, Milligan DW.
    Clin Infect Dis; 2000 Dec; 31(6):1516-8. PubMed ID: 11096028
    [Abstract] [Full Text] [Related]

  • 3. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F, Alvares C, Riley U, Ethell M, Cunningham D, Treleaven J, Ashley S, Bendig J, Morgan G, Potter M.
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [Abstract] [Full Text] [Related]

  • 4. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Chakrabarti S, Collingham KE, Holder K, Fegan CD, Osman H, Milligan DW.
    Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency.
    Stankova J, Carret AS, Moore D, McCusker C, Mitchell D, Davis M, Mazer B, Jabado N.
    Pediatr Transplant; 2007 Mar; 11(2):209-13. PubMed ID: 17300503
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G, Mattsson J, Sparrelid E, Ljungman P.
    Transplantation; 2009 Nov 27; 88(10):1222-6. PubMed ID: 19935377
    [Abstract] [Full Text] [Related]

  • 10. Paramyxovirus infection in lung transplant recipients.
    Wendt CH, Fox JM, Hertz MI.
    J Heart Lung Transplant; 1995 Nov 27; 14(3):479-85. PubMed ID: 7654733
    [Abstract] [Full Text] [Related]

  • 11. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
    Small TN, Casson A, Malak SF, Boulad F, Kiehn TE, Stiles J, Ushay HM, Sepkowitz KA.
    Bone Marrow Transplant; 2002 Feb 27; 29(4):321-7. PubMed ID: 11896429
    [Abstract] [Full Text] [Related]

  • 12. Human parainfluenza type 4 virus (hPIV4) infection provoking many questions regarding the role of this virus as the causative agent of respiratory tract infections in the post-transplant setting.
    Hohenthal U, Nikoskelainen J, Vainionpää R, Peltonen R, Routamaa M, Itälä M, Kotilainen P.
    Bone Marrow Transplant; 2002 Apr 27; 29(7):629-30. PubMed ID: 11979316
    [No Abstract] [Full Text] [Related]

  • 13. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.
    Hassan IA, Chopra R, Swindell R, Mutton KJ.
    Bone Marrow Transplant; 2003 Jul 27; 32(1):73-7. PubMed ID: 12815481
    [Abstract] [Full Text] [Related]

  • 14. Parainfluenza virus respiratory infection after bone marrow transplantation.
    Wendt CH, Weisdorf DJ, Jordan MC, Balfour HH, Hertz MI.
    N Engl J Med; 1992 Apr 02; 326(14):921-6. PubMed ID: 1311800
    [Abstract] [Full Text] [Related]

  • 15. Parainfluenza virus 3 infection pre- and post-haematopoietic stem cell transplantation: re-infection or persistence?
    Templeton KE, Bredius RG, Scheltinga SA, Claas EC, Vossen JM, Kroes AC.
    J Clin Virol; 2004 Apr 02; 29(4):320-2. PubMed ID: 15018862
    [Abstract] [Full Text] [Related]

  • 16. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S, Duenzinger U, Wolf T, Ajib S, Mousset S, Berger A, Martin H, Serve H, Bug G.
    Transpl Infect Dis; 2013 Aug 02; 15(4):435-40. PubMed ID: 23692664
    [Abstract] [Full Text] [Related]

  • 17. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
    Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E.
    Bone Marrow Transplant; 2001 Aug 02; 28(3):271-5. PubMed ID: 11535995
    [Abstract] [Full Text] [Related]

  • 18. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR, Scott AI, Morton JM, Aboyoun CL, Plit ML, Carter IW, Malouf MA.
    J Heart Lung Transplant; 2005 Dec 02; 24(12):2114-9. PubMed ID: 16364859
    [Abstract] [Full Text] [Related]

  • 19. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
    Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I, Jacobson K, Neumann J, Ippoliti C, Mallik S, Whimbey E.
    Bone Marrow Transplant; 2000 Apr 02; 25(7):751-5. PubMed ID: 10745261
    [Abstract] [Full Text] [Related]

  • 20. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.
    Pediatr Infect Dis J; 2007 Dec 02; 26(12):1089-93. PubMed ID: 18043443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.